EUCTR2004-002669-19-IT进行中（未招募）不适用
A double-blind, randomised, controlled, multi-centre safety study of a refrigerator-stable formulation of VARIVAX® in healthy 12 to 15 month-old infants.
AVENTIS PASTEUR MSD S.P.A.0 个研究点开始时间: 2005年6月7日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
A study evaluating the effect of Filgotinib dose de-escalation in patients with ulcerative colitis in remissioCTRI/2023/05/052646Galapagos NV
进行中（未招募）
1 期
A study evaluating the effect of filgotinib dose de-escalation in patients with ulcerative colitis in remissiolcerative colitis (UC)MedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856EUCTR2022-000719-30-ITGALAPAGOS NV80
进行中（未招募）
1 期
A study evaluating the effect of filgotinib dose de-escalation in patientswith ulcerative colitis in remissioulcerative colitis (UC)MedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2022-000719-30-CZGalapagos NV80
进行中（未招募）
1 期
A study evaluating the effect of filgotinib dose de-escalation in patients with ulcerative colitis in remissioEUCTR2022-000719-30-ESGalapagos NV80
进行中（未招募）
1 期
A study evaluating the effect of filgotinib dose de-escalation in patientswith ulcerative colitis in remissioEUCTR2022-000719-30-FRGalapagos NV80